Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia.

Naithani R, Asim M, Abdelhaleem M, Punnett A.

Haematologica. 2012 Sep;97(9):e31-2. doi: 10.3324/haematol.2012.068288. No abstract available.

2.

CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.

Solano-Genesta M, Tarín-Arzaga L, Velasco-Ruiz I, Lutz-Presno JA, González-Llano O, Mancías-Guerra C, Rodríguez-Romo L, Ruiz-Delgado GJ, Ruiz-Argüelles GJ, Jaime-Pérez JC, Gómez-Almaguer D.

Hematology. 2012 Mar;17(2):66-70. doi: 10.1179/102453312X13221316477741.

PMID:
22664043
3.

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.

Dworzak MN, Fritsch G, Panzer-Grümayer ER, Mann G, Gadner H.

Leuk Lymphoma. 2000 Jul;38(3-4):295-308. Review.

PMID:
10830736
4.

Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.

Haematologica. 1998 Nov;83(11):967-73.

5.

Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.

Jeha S, Behm F, Pei D, Sandlund JT, Ribeiro RC, Razzouk BI, Rubnitz JE, Hijiya N, Howard SC, Cheng C, Pui CH.

Blood. 2006 Nov 15;108(10):3302-4. Epub 2006 Aug 8.

6.

CD20 and Outcome of Childhood Precursor B-cell Acute Lymphoblastic Leukemia: A Meta-analysis.

Ou DY, Luo JM, Ou DL.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e138-42. doi: 10.1097/MPH.0000000000000256.

PMID:
25222059
7.

Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.

Ratei R, Schabath R, Karawajew L, Zimmermann M, Möricke A, Schrappe M, Ludwig WD.

Klin Padiatr. 2013 May;225 Suppl 1:S34-9. doi: 10.1055/s-0033-1337961. Epub 2013 May 22.

PMID:
23700065
8.

High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.

Shalapour S, Hof J, Kirschner-Schwabe R, Bastian L, Eckert C, Prada J, Henze G, von Stackelberg A, Seeger K.

Haematologica. 2011 Nov;96(11):1627-35. doi: 10.3324/haematol.2011.047993. Epub 2011 Aug 9.

9.

Initial frequency of CD34+/CD38 - cells is not correlated with minimal residual disease level in 73 Chinese children with B-cell precursor acute lymphoblastic leukemia.

Feng JH, Tang YM, Shen HQ, Song H, Yang SL, Shi SW, Xu WQ.

Leuk Lymphoma. 2013 Sep;54(9):2073-5. doi: 10.3109/10428194.2013.765566. Epub 2013 Feb 1. No abstract available.

PMID:
23323948
10.

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.

Borowitz MJ, Shuster J, Carroll AJ, Nash M, Look AT, Camitta B, Mahoney D, Lauer SJ, Pullen DJ.

Blood. 1997 Jun 1;89(11):3960-6.

11.

The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia.

Wang W, Gao L, Li Y, Li ZL, Gong M, Huang FZ, Chen YR, Zhang CX, Gao YY, Ma YG.

Leuk Lymphoma. 2016 May;57(5):1174-81. doi: 10.3109/10428194.2015.1070153. Epub 2015 Oct 5.

PMID:
26436205
12.

Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.

Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G; I-BFM-ALL-FCM-MRD-Study Group.

Haematologica. 2003 Nov;88(11):1245-52.

13.

Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia.

Orgel E, Tucci J, Alhushki W, Malvar J, Sposto R, Fu CH, Freyer DR, Abdel-Azim H, Mittelman SD.

Blood. 2014 Dec 18;124(26):3932-8. doi: 10.1182/blood-2014-08-595389. Epub 2014 Oct 27.

14.

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups.

Scrideli CA, Assumpção JG, Ganazza MA, Araújo M, Toledo SR, Lee ML, Delbuono E, Petrilli AS, Queiróz RP, Biondi A, Viana MB, Yunes JA, Brandalise SR, Tone LG.

Haematologica. 2009 Jun;94(6):781-9. doi: 10.3324/haematol.2008.003137.

15.

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

Dworzak MN, Schumich A, Printz D, Pötschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H.

Blood. 2008 Nov 15;112(10):3982-8. doi: 10.1182/blood-2008-06-164129. Epub 2008 Sep 9.

16.

Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.

Lauten M, Möricke A, Beier R, Zimmermann M, Stanulla M, Meissner B, Odenwald E, Attarbaschi A, Niemeyer C, Niggli F, Riehm H, Schrappe M.

Haematologica. 2012 Jul;97(7):1048-56. doi: 10.3324/haematol.2011.047613. Epub 2012 Jan 22.

17.

Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.

Gobbi G, Mirandola P, Malinverno C, Sponzilli I, Carubbi C, Ricci F, Binazzi R, Basso G, Giuliani-Piccari G, Ramazzotti G, Pasquantonio G, Cocco L, Vitale M.

Int J Oncol. 2008 Aug;33(2):371-4.

PMID:
18636158
18.

Frequencies of immature CD34 + CD38 - and CD34 + CD38-CD19 + blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia.

Shman TV, Movchan LV, Aleinikova OV.

Leuk Lymphoma. 2013 Nov;54(11):2560-2. doi: 10.3109/10428194.2013.778404. Epub 2013 Apr 11. No abstract available.

PMID:
23432723
19.

Clinical significance of minimal residual disease in young adults with standard-risk/Ph-negative precursor B-acute lymphoblastic leukemia: results of prospective study.

Salah-Eldin M, Abousamra NK, Azzam H.

Med Oncol. 2014 May;31(5):938. doi: 10.1007/s12032-014-0938-z. Epub 2014 Apr 2.

PMID:
24692146
20.

NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.

Meyerson HJ, Blidaru G, Edinger A, Osei E, Schweitzer K, Fu P, Ho L.

Am J Clin Pathol. 2012 Jan;137(1):39-50. doi: 10.1309/AJCP6VDBL4BRXRQA.

PMID:
22180477

Supplemental Content

Support Center